Six-Month Outcomes From the First-in-Human, Single-Arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions - Zeller, T; Brechtel, K; Meyer, DR (J Endovasc Ther, 2020)
et al.